NLRC5 potentiates anti-tumor CD8+ T cells responses by activating interferon-ß in endometrial cancer.
Transl Oncol
; 36: 101742, 2023 Oct.
Article
in En
| MEDLINE
| ID: mdl-37531863
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Type of study:
Prognostic_studies
Language:
En
Journal:
Transl Oncol
Year:
2023
Type:
Article
Affiliation country:
China